TGF-β also promotes the conversion of tumor associated pDCs into a suppressive phenotype by inhibiting IFN-α and MHCI expression in cells activated by the toll like receptor 9 (TLR9) agonist, CpG. The gene discussed is TGFB1; the disease is neoplasm.